Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Intercede lifts FY outlook on new order, 'strong' trading

(Sharecast News) - Intercede said on Friday that its full-year performance was set to be ahead of market expectations following an order for a new licence test environment and further "strong" trading. Current market expectations for the year ending 31 March 2024 are for revenue of £19.2m and adjusted EBITDA of £5.6m.

Intercede announced an order for a new licence test environment for an existing US Federal Agency. This, combined with anticipated additional conversion of its existing pipeline, means it now expects its financial performance to be ahead of market expectations for FY24 and creates further contracted revenue backlog for FY25.

"With this momentum coinciding with the launch of our new product release, MyID MFA v5, the group is in a robust position to execute on its forthcoming plans for FY25 and beyond," it said.

Chief executive Klaas van der Leest said: "With this being our third raise in so many months, FY24 has been an exceptional year for the group, reflecting the quality of the group's products and services.

"Our pipeline continues to develop in line with our expectations and we look forward to the commencement of the new financial year."

At 0850 GMT, the shares were up 14% at 113p.

Share this article

Related Sharecast Articles

Liberum upgrades Pets at Home to 'buy', shares surge
(Sharecast News) - Pets at Home rallied on Monday as Liberum upgraded its stance on the shares to 'buy' from 'hold' and lifted the price target to 360p from 290p.
Strip Tinning names Mark Perrins as group CEO
(Sharecast News) - Connection systems supplier Strip Tinning has appointed Mark Perrins as group chief executive officer, joining the board of directors with immediate effect.
Hvivo scores £2.5m contract for Omicron characterisation study
(Sharecast News) - Contract research organisation Hvivo has secured a £2.5m contract with a mid-sized pharmaceutical company to initiate an Omicron characterisation study after the manufacture of its Omicron BA.5 challenge agent was successfully completed in 2023.
MP Evans purchases minority stakes in Indonesian subsidiaries
(Sharecast News) - Palm oil producer MP Evans has purchased a 5% minority holding in the majority of its Indonesian subsidiary trading companies.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.